QA: Organogenesis Holdings Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001661181_2021_Organogenesis_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001661181, Organogenesis Holdings Inc

  xvar xval
0 AssetsCurrent 174,344,000
1 IntangibleAssetsNetIncludingGoodwill 59,394,000
2 PropertyPlantAndEquipmentNet 60,068,000
3 remainder_Assets 688,000
4 LiabilitiesCurrent 68,217,000
5 LiabilitiesNoncurrent 7,971,000
6 remainder_Liabilities 72,222,000
7 CostOfGoodsAndServicesSold 87,319,000
8 SellingGeneralAndAdministrativeExpense 203,478,000
9 ResearchAndDevelopmentExpense 20,086,000
10 remainder_Expenses 530,000
11 remainder_Revenues 338,298,000
12 remainder_NetIncome -8,936,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 294,494,000
1 Liabilities 148,410,000
2 Expenses 311,413,000
3 Revenues 338,298,000
4 StockholdersEquity 146,084,000
5 NetIncome 17,949,000
6 ComprehensiveNetIncome 17,949,000
7 BaseVar 550,775,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.52
9 EconomicCapitalRatio 2.69

Edgar->Model Mapping

Feature Distribution

Change over Time